Filters
Early-life maternal warmth shapes adolescents’ mental and physical health, with perceptions of social safety mediating this effect, the Millennium cohort study has shown.
Individuals with autism spectrum disorder face an increased risk of Parkinson’s disease (PD), independent of depression or antidepressant use and antipsychotic exposure, according to a nationwide population-based prospective cohort study.
Maternal use of the migraine drug triptans before or during pregnancy does not appear to put infants at risk of developing neurodevelopmental disorders, according to a study.
In the treatment of patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonists (GLP1-RAs) do not increase the risk of psychiatric adverse events or worsen depressive symptoms but rather confer improvements in quality of life (QOL) and eating behaviour, according to the results of a meta-analysis.
The KV7 potassium channel opener azetukalner helps improve symptoms of major depressive disorder (MDD) in adults, according to the results of the proof-of-concept, phase II X-NOVA study.
Intracavernosal injection (ICI) of aviptadil with phentolamine mesylate (AvP) demonstrates efficacy in more than half of the men with refractory erectile dysfunction (ED) who participated in a recent study.
For older adults who received treatment with antipsychotics to manage delirium, medication discontinuation leads to better outcomes, including reduced risks of all-cause rehospitalization and mortality, compared with continued use, according to a study.
Body weight appears to affect a person’s sexual desire, suggests a study.
A significant association exists between refractory gastroesophageal disease (RGERD) and increased methane (CH4) levels, reports a study.
A new mobile application, Bounce Back Now (BBN), may help reduce postdisaster symptoms of post-traumatic stress, depressed mood, and sleep disturbance, according to a study.
